Cultrera, R. (2024). Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview. Global and Regional Health Technology Assessment, 11(Suppl. 2), 1–4. https://doi.org/10.33393/grhta.2024.3108